These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1240638)

  • 21. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unilateral striatal dopamine denervation: reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behaviour.
    Costall B; Kelly ME; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):29-35. PubMed ID: 6433208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course of apomorphine-induced circling behaviour after striatal dopamine receptor denervation.
    Oberlander C; Dumont C; Boissier JR
    Eur J Pharmacol; 1980 Mar; 62(1):107-10. PubMed ID: 7189465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of morphine on circling behaviour in rats with 6-hydroxydopamine striatal lesions and electrolesions of the raphe nucleus.
    Slater P
    Pharmacol Biochem Behav; 1981 May; 14(5):625-30. PubMed ID: 7195577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of turning behaviour by clozapine in mice with unilateral destruction of dopaminergic nerve terminals.
    Pycock CJ; Tarsy D; Marsden CD
    J Pharm Pharmacol; 1975 Jun; 27(6):445-7. PubMed ID: 237097
    [No Abstract]   [Full Text] [Related]  

  • 26. Does contralateral circling involve action of drugs on hyposensitive striatal dopamine receptors in the hemisphere contralateral to denervation?
    Costall B; Kelly ME; Naylor RJ
    Neuropharmacology; 1983 Mar; 22(3):295-302. PubMed ID: 6133233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD; Creese I
    Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.
    Blunt S; Jenner P; Marsden CD
    Neuroscience; 1991; 40(2):453-64. PubMed ID: 1902916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency?
    Singhal RL; Rastogi RB; Lapierre YD
    J Neural Transm; 1983; 56(2-3):127-38. PubMed ID: 6306165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of blocking catecholamine uptake on amphetamine-induced circling behaviour in mice with unilateral destruction of striatal dopaminergic nerve terminals.
    Pycock C; Milson JA; Tarsy D; Marsden CD
    J Pharm Pharmacol; 1976 Jun; 28(6):530-2. PubMed ID: 7659
    [No Abstract]   [Full Text] [Related]  

  • 32. The production of asymmetry and circling behaviour following unilateral, intrastriatal administration of neuroleptic agents: a comparison of abilities to antagonise striatal function.
    Costall B; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(1-2):79-86. PubMed ID: 6141060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesias.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Apr; 36(2):423-9. PubMed ID: 945168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway.
    Reavill C; Leigh N; Jenner P; Marsden CD
    Exp Brain Res; 1979 Oct; 37(2):309-16. PubMed ID: 315328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circling behavior in rats with 6-hydroxydopamine or electrolytic nigral lesions,
    Iwamoto ET; Loh HH; Way EL
    Eur J Pharmacol; 1976 Jun; 37(2):339-56. PubMed ID: 986305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo.
    Blaha CD; Lane RF
    Neurosci Lett; 1987 Jul; 78(2):199-204. PubMed ID: 2888060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction of clonidine with dopamine-dependent behaviour in rodents.
    Pycock CJ; Jenner PG; Marsden CD
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR; Grant LD; Breese GR
    Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
    [No Abstract]   [Full Text] [Related]  

  • 40. [Thyrotropin-releasing hormone (TRH): Enhancement of dopamine dependent circling behavior and its own circling-inducing effect in unilateral striatal lesioned animals (author's transl)].
    Fukuda N; Miyamoto M; Narumi S; Nagai Y; Shima T; Nagawa Y
    Nihon Yakurigaku Zasshi; 1979 Apr; 75(3):251-70. PubMed ID: 231554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.